Tesaglitazar

Tesaglitazar Uses, Dosage, Side Effects, Food Interaction and all others data.

Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.

Treatment with tesaglitazar lowered fasting plasma glucose, improved glucose tolerance, substantially reduced fasting and postload insulin levels, and markedly lowered fasting TG and improved lipid tolerance.

Table Of contents

• Tesaglitazar
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Tesaglitazar
Generic	Tesaglitazar
Tesaglitazar Other Names	Tesaglitazar
Type
Formula	C20H24O7S
Weight	Average: 408.465 Monoisotopic: 408.124273812
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in diabetes mellitus type 2.

Innovators Monograph

You find simplified version here Tesaglitazar